Mashael AlFaifi
Overview
Explore the profile of Mashael AlFaifi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
49
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alissa A, Korayem G, Aljuhani O, AlFaifi M, Alnajjar L, Souaan N, et al.
Ther Clin Risk Manag
. 2025 Feb;
21:177-189.
PMID: 40008079
Background: Limited evidence is available regarding the safety and effectiveness of early high protein intake in critically ill patients with COVID-19. Therefore, this study aims to assess the safety of...
2.
Basilim A, Eljaaly K, Aljuhani O, Korayem G, Altebainawi A, Aldhmadi W, et al.
J Intensive Care Med
. 2024 Nov;
40(1):74-84.
PMID: 39552466
Dexmedetomidine (DEX) is a highly favored sedative agent in critically ill patients owing to its anxiolytic and analgesic properties, lower risk of delirium, and minimal respiratory depression. Additionally, DEX exhibits...
3.
Alsulami S, Alghanem A, AlShuraim R, Al Sulaiman K, Abdelwahab O, Aljohani S, et al.
BMC Pediatr
. 2024 Aug;
24(1):504.
PMID: 39112949
Background: Down syndrome (DS), or Trisomy 21, is defined by the existence of an additional chromosome 21. Various physiological considerations in DS patients might lead to challenges in adequate pain...
4.
Aljuhani O, Al Sulaiman K, Alkofide H, AlFaifi M, Alshehri A, Aljohani S, et al.
Tob Induc Dis
. 2024 Aug;
22.
PMID: 39109253
Introduction: The effectiveness of nicotine replacement therapy (NRT) in critically ill patients remains uncertain, as conflicting research results have been reported. Despite potential side effects and inconsistent data on safety...
5.
Al Sulaiman K, Aljuhani O, Korayem G, AlFaifi M, Alharthi A, Alshehri A, et al.
Infect Drug Resist
. 2024 Jul;
17:3161-3171.
PMID: 39050827
Background: There is increasing evidence suggesting that ABO blood type may play a role in the immunopathogenesis of COVID-19 infection. In addition to ABO blood type, the Rhesus (Rh) factor...
6.
Al Sulaiman K, Aljuhani O, Alkofide H, Aljohani M, Badreldin H, Al Harbi M, et al.
Thromb J
. 2024 May;
22(1):43.
PMID: 38778323
Background: Recent guidelines recommend using direct oral anticoagulants (DOACs) as first-line agents in patients with non-valvular atrial fibrillation (NVAF). Research is currently investigating the use of Apixaban in underweight patients,...
7.
Aljuhani O, Al Sulaiman K, Korayem G, Altebainawi A, Alshaya A, Nahari M, et al.
Saudi Pharm J
. 2024 Apr;
32(5):102061.
PMID: 38596319
Backgrounds: Ketamine possesses analgesia, anti-inflammation, anticonvulsant, and neuroprotection properties. However, the evidence that supports its use in mechanically ventilated critically ill patients with COVID-19 is insufficient. The study's goal was...
8.
Alzahrani A, Alkofide H, Joharji H, Korayem G, Aljohani S, Alshareef H, et al.
Clin Appl Thromb Hemost
. 2023 Dec;
29:10760296231218215.
PMID: 38115686
Objectives: Bleeding remains a common complication post-thoracic surgery. Although intravenous tranexamic acid (TXA) has been shown to decrease blood loss, its use has been associated with adverse effects. Accordingly, topical...
9.
Al Sulaiman K, Aljuhani O, Korayem G, Altebainawi A, Vishwakarma R, AlFaifi M, et al.
Clin Appl Thromb Hemost
. 2023 Dec;
29:10760296231218216.
PMID: 38073058
The use of erythropoietin-stimulating agents (ESAs) as adjunctive therapy in critically ill patients with COVID-19 may have a potential benefit. This study aims to evaluate the effect of ESAs on...
10.
Alfayez O, AlFaifi M, Alkhezi O, Alahmed A, Alalwan A
Saudi Pharm J
. 2023 Nov;
31(12):101842.
PMID: 38028214
Background: The aim of this study is to identify potential barriers to conducting and publishing pharmacy residency research. Methods: A cross-sectional study surveyed pharmacy residents in Saudi Arabia from August...